Preventing platinum-induced ototoxicity in children-is there a potential role for sodium thiosulfate?
Skinner
Roderick
R
Department of Paediatric and Adolescent Oncology, Newcastle upon Tyne Hospitals NHS Trust, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom. Roderick.Skinner@ncl.ac.uk
D000970:Antineoplastic Agents / Q000009:adverse effects*; D001932:Brain Neoplasms / Q000188:drug therapy; D016190:Carboplatin / Q000009:adverse effects; D002614:Chelating Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D006319:Hearing Loss, Sensorineural / Q000139:chemically induced / Q000517:prevention & control*; D006801:Humans; D007223:Infant; D017671:Platinum Compounds / Q000009:adverse effects*; D013885:Thiosulfates / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D002614:Chelating Agents; D017671:Platinum Compounds; D013885:Thiosulfates; D016190:Carboplatin; C017717:sodium thiosulfate